Shareholder Update Webinar Hosted by CNS Response CEO

COSTA MESA, CA--(Marketwire - March 30, 2010) - CNS Response, Inc. (OTCBB: CNSO) today announced that CEO George Carpenter will be conducting a webinar to provide a shareholder update. The shareholder update webinar will be held Monday, April 5, at 12:30 p.m. Pacific (PDT), 3:30 p.m. Eastern (EDT). Joining Mr. Carpenter will be CNS Response President and Chief Medical Officer Daniel Hoffman, M.D., and the company’s new Chief Financial Officer, Paul Buck.

To receive joining instructions, please register for the webinar by clicking on the following link: http://events.meetingbridge.com/Register/?06123158745. This event consists of a visual portion conducted via web conference and an audio portion conducted via teleconference. The dial-in numbers and joining instructions are provided after registering online.

System requirements:

• Windows, Unix/Linux OS with IE 5.0+, Netscape 7.0+, AOL 7.0+, or Mozilla 1.0+
• MacIntosh OS with Netscape 7.0+ActiveScripting/JavaScript and Cookies are enabled in the browser
• An internet connection speed of 56Kbps or faster

If you have questions pertaining to the shareholder update webinar, please contact Suzanne Schnitzer at 949.553.9748 or Suzanne@McCloudCommunications.com.

About CNS Response
Today, most physicians are able to base treatment on objective test data, such as EKGs, MRIs, blood tests, etc. Broadly speaking, such advances have not yet come to those physicians practicing psychiatry.

CNS Response has developed a patented data-analysis capability that, with the help of a simple, non-invasive EEG, will analyze a patient’s brain waves and compare the results to an extensive patient outcomes database. The process produces a rEEG® report providing a psychiatrist with guidance to personalize medication regimens for a patient, based on the patient’s own brain physiology. To read more about the benefits this patented technology provides physicians, patients and insurers, please visit www.cnsresponse.com.